Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain

Novartis' Cosentyx Phase 3 REPLENISH trial for polymyalgia rheumatica met primary and secondary endpoints, showing ...
Seeking Alpha

Amgen posts Phase 3 trial win for Repatha in major cardiovascular events

Amgen (NASDAQ:AMGN) announced on Thursday that its PCSK9 inhibitor Repatha (evolocumab) reached the primary endpoints in a Phase 3 trial designed to evaluate its effect in reducing major adverse ...
FiercePharma

Amgen unveils DTC platform with 60% discount on Repatha, giving US lowest price of G7 nations

Amgen has joined the wave of major drugmakers setting up direct-to-consumer programs amid President Donald Trump’s call for more DTC options to lower U.S. drug prices. The "AmgenNow" program, launched ...
abc27

AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.

THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha ® (evolocumab). This follows ...

Should I take a magnesium supplement? Will it help me sleep or prevent muscle cramps?

You will only need a magnesium supplement if you show signs of low magnesium. One of the most common signs is muscle spasms ...
STAT

Amgen says its cholesterol shot prevented heart problems in a broad population

Matthew Herper covers medical innovation — both its promise and its perils. Amgen said Thursday that its cholesterol-lowering shot, Repatha, prevented a composite of heart disease death, heart attack, ...
Investing

Amgen stock rises as Bernstein reiterates Outperform rating on Repatha data

Investing.com - Amgen (NASDAQ:AMGN), the $160 billion biotech giant with a robust 3.2% dividend yield, saw its stock rise after Bernstein SocGen Group reiterated an Outperform rating with a $335.00 ...
Hosted on MSN

What actually causes muscle cramps

Muscle cramps are sudden, involuntary contractions that can cause sharp, intense pain lasting from a few seconds to several minutes. They often strike during exercise, dehydration, or even while ...
Yahoo Finance

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%

Amgen AMGN announced the launch of a new direct-to-consumer (DTC) program called AmgenNow, which will offer significant discounts on its marketed drugs. The company has initiated this DTC program with ...
Yahoo Finance

LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS

Adding Repatha to Standard Therapy of Statins or Other LDL-C Lowering Treatments Significantly Reduces Cardiovascular Events Compared with Standard Therapy Alone Repatha is Now the First and Only ...
Investing

Amgen stock maintains Outperform rating at Oppenheimer after positive Repatha trial

Investing.com - Oppenheimer has reiterated an Outperform rating and $380.00 price target on Amgen (NASDAQ:AMGN), a $160 billion biotech giant with a "GREAT" financial health score according to ...